Delivery Order SPE2DR25D7061-SPE2DR26F7WTT
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,682.57 by the Defense Logistics Agency (DLA) on December 5, 2025, for the supply of Brilinta 90 mg tablets (60-count packages). The contract carries a firm fixed price structure with an ultimate completion date of December 8, 2025, and was awarded on a competitive basis with no set-aside designation. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,635.82 for 60 tablets of Brilinta 90 mg on December 18, 2025, with an ultimate completion date of December 19, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order falls under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,755.48 for 60 tablets of Brilinta 90 mg, a pharmaceutical product used in cardiovascular treatment. This firm fixed-price, non-set-aside delivery order was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,400.73 by the Defense Logistics Agency on December 19, 2025, for the supply of Brilinta 90 mg tablets (60-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 22, 2025. The award serves the Defense Logistics Agency's Medical Supply Chain, which procures critical pharmaceutical products to...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $4,619.05. The order, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a firm fixed-price contract with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as both the place of performance and the company's headquarters, positioning...
- The Defense Logistics Agency awarded a delivery order valued at $1,453.02 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) on November 6, 2025, with completion scheduled for November 7, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count) valued at $15,309.90. This non-set-aside, competitively awarded contract carries a firm fixed price structure with a completion date of November 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single pharmaceutical transaction executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Brilinta 60 mg tablets (60-count) on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed price delivery order, valued at $1,516.38, represents a non-competitive set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,472.78 to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count packages) on December 16, 2025, with an ultimate completion date of December 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a fulfillment under the company's broader pharmaceutical supply agreement. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $2,638.44 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Brilinta 60 mg tablets (60-count package). This is a firm fixed-price, non-set-aside contract with a completion date of December 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child action under its...
- SPE2DR25D7061Indefinite Delivery Contract
- SPE2DR25D7061-SPE2DR26F7WTTDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,340.64 on December 22, 2025, for the supply of Brilinta 90 mg tablets (60-count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion vehicle designated SPE2DX that runs through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor for military and veteran healthcare systems. As a prime contractor under the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceutical products across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers. The company's extensive federal contract portfolio demonstrates its capability to fulfill federal procurement requirements through open competition, with delivery orders ranging from minimal to substantial values and covering brand-name and generic medications, vaccines, and specialized medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 12/21/25 |